Therapeutic activity of a glibenclamide-phenformin association in maturity-onset diabetes
Gervasini, A.
Minerva Medica 65(73): 3835-3842
1974
ISSN/ISBN: 0026-4806 PMID: 4214284 Document Number: 80340
Document emailed within 1 workday
Related Documents
Bunnag, S.C.; Israsena, T.; Watananukul, P. 1972: Blood coagulation in maturity--onset diabetics before and after treatment with glibenclamide Journal of the Medical Association of Thailand 55(2): 80-86Haider, Z.; Obaidullah, S.; Fayyaz-ud-Din 1976: Comparative study of glibenclamide and chlorpropamide in newly diagnosed maturity onset diabetics JPMA. Journal of the Pakistan Medical Association 26(2): 23-26
Haider, Z.; Obaidullah, S.; Fayyaz-ud-Din 1976: Comparative study of glibenclamide & chlorpropamide in newly diagnosed maturity onset diabetics Jpma. Journal of the Pakistan Medical Association 26(2): 23-26
Thorpe, R.M. 1981: Diabetes mellitus--short-stay treatment in a specialised unit. 2. Stabilisation of a patient with maturity onset diabetes Nursing Times 77(19): 810-812
Beaulieu, M.D. 1980: Hyperglycemia and the complications of maturity-onset diabetes Canadian Medical Association Journal 122(8): 884-889
Palmieri, G.; Alkabes, M. 1977: Treatment of overweight diabetics with a combination of glibenclamide and phenformin La Clinica Terapeutica 81(6): 537-546
Samaan, M.C.; Brennan, A.; Fitzgerald, H.; Roche, E.F.; Hoey, H.M.C.V. 2005: Maturity Onset Diabetes in the Young (MODY) type 3 Irish Medical Journal 98(1): 28-29
Viswanathan, M.; Ramachandran, A.; Snehalatha, C.; Viswanathan, M. 1981: Monocomponent insulin in maturity onset diabetes mellitus Journal of the Indian Medical Association 76(5): 73-75
Spanár, E.; Uhrín, P.; Levcík, A.; Záhradný, V. 1977: Pathogenetic relationships between obesity and maturity-onset diabetes Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 32(11): Suppl: 170-171
Shah, D.R.; Gehlot, R.S.; Dhoka, L.C. 1986: Guar incorporated diet in maturity onset diabetes mellitus Journal of the Association of Physicians of India 34(5): 353-354
Muñoz, S.; Durruty, P.; García de los Ríos, M. 1987: Phenotypic characteristics and insulin secretion in 25 cases of non-insulin-dependent diabetes mellitus, subtype MODY (maturity onset diabetes in the young people) Revista Medica de Chile 115(5): 397-403
Tack, C.J. 1995: Current developments in the area of maturity onset diabetes of the young (MODY) Nederlands Tijdschrift Voor Geneeskunde 139(42): 2127-2129
Beringer, A. 1974: Oral antidiabetic therapy with delayed-action glibenclamide and phenformin in fixed combination Minerva Medica 65(60): 3127-3139
Thomas, D.J.; Alberti, K.G. 1978: Hyperglycaemic effects of Hartmann's solution during surgery in patients with maturity onset diabetes British Journal of Anaesthesia 50(2): 185-188
Hansen, T.; Urhammer, S.ør.A.; Pedersen, O.B. 2002: Maturity-onset diabetes of the young--MODY. Molecular-genetic, pathophysiological and clinical characteristics Ugeskrift for Laeger 164(15): 2017-2022
Makino, M.; Hayashi, Y.; Ito, H.; Morikawa, A. 1990: Principal component analysis for microalbuminuria in patients with noninsulin-dependent, maturity-onset diabetes mellitus Rinsho Byori. Japanese Journal of Clinical Pathology 38(1): 65-70
Hanefeld, M.; Naumann, H.J.; Stötzner, H.; Haller, H. 1975: Studies on the influence of body weight and form of therapy on the development of fatty liver in maturity-onset diabetes Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 30(10): 59-60
Bruining, G.J. 2000: Association between infant growth before onset of juvenile type-1 diabetes and autoantibodies to IA-2. Netherlands Kolibrie study group of childhood diabetes Lancet 356(9230): 655-656
Ravindranath, R.; Thomas, I.M. 1995: Finger ridge count and finger print pattern in maturity onset diabetes mellitus Indian Journal of Medical Sciences 49(7): 153-156
Mirakian, R.; Bottazzo, G.F.; Doniach, D. 1980: Autoantibodies to duodenal gastric-inhibitory-peptide (GIP) cells and to secretin (S) cells in patients with coeliac disease, tropical sprue and maturity-onset diabetes Clinical and Experimental Immunology 41(1): 33-42